Cytoprotective action of renalase in diabetic kidney disease: an update on its association with cardiovascular disease and COVID -19
Biomedicine (India)
; 42(6):1114-1121, 2022.
Article
in English
| EMBASE | ID: covidwho-2206932
ABSTRACT
Renalase is a mono amine oxidase enzyme that can metabolise the active catecholamines in the body. Renalase is typically expressed in the cardiovascular system, skeletal muscle, and renal system. Renalase gene is important in human diseases and is known to break down catecholamines in the blood. Gene for renalase as extreme frequency of congestive heart failure disease in people with long term renal disease and other disorders was shown to be explained by a protein that is released by the kidney. Recent advances have increased our understanding of its structure, enzymatic activity, mechanisms of action, relationships with human disease states, and potential therapeutic value. An enzyme description of renalase is provided in this review, along with COVID-19 infection. Copyright © 2022, Indian Association of Biomedical Scientists. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Biomedicine (India)
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS